DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off
Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s
President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel
NCI Clarifies Plan For Review Of Epidemiologic Research
Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial
Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers
Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment
Emerging Technologies: Company To Expand Program Studying Polymer Platinates
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
